Norman Jacobowitz
Family · Manassas, VANPI 1265746317
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by AbbVie at 48.8% of the total. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 483 payments — averaging $113.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$27K
- Axsome Therapeutics, Inc.$23K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$599
- Supernus Pharmaceuticals, Inc.$505
- Lundbeck LLC$502
- plus $2K from 13 others
What the payments were for
- Consulting fees$12,56323%
- Speaking & faculty fees$29,40054%
- Travel & lodging$4,2558%
- Food & beverage$8,42415%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 143 | $26,683 |
| Axsome Therapeutics, Inc. | 75 | $23,332 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 84 | $1,408 |
| Otsuka America Pharmaceutical, Inc. | 34 | $599 |
| Supernus Pharmaceuticals, Inc. | 13 | $505 |
| Lundbeck LLC | 30 | $502 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $368 |
| Sunovion Pharmaceuticals Inc. | 29 | $271 |
| Corium, LLC | 21 | $240 |
| Ironshore Pharmaceuticals Inc. | 3 | $176 |
| E.r. Squibb & Sons, L.L.C. | 4 | $151 |
| Alkermes, Inc. | 4 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $89 |
| Johnson & Johnson | 4 | $65 |
| Avanir Pharmaceuticals, Inc. | 5 | $65 |
| Neurocrine Biosciences, Inc. | 2 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Neos Therapeutics, LP | 1 | $21 |
| Tris Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,688 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 12 | $20,050 |
| AuvelityDextromethorphan Hbr/Bupropion | 15 | $16,128 |
| Quetiapine Fumarate | 19 | $1,733 |
| Ziprasidone Hcl | 12 | $1,355 |
| Paliperidone ErPaliperidone | 12 | $1,273 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $1,091 |
| Hydroxyzine Hcl | 21 | $826 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $794 |
| Mirtazapine | 25 | $711 |
| Gabapentin | 27 | $430 |
| Escitalopram Oxalate | 20 | $334 |
| Buspirone Hcl | 17 | $318 |
| Paroxetine Hcl | 15 | $299 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $249 |
| Bupropion XlBupropion Hcl | 13 | $245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,408 | $20,05012 claims |
| Axsome Therapeutics, Inc.Auvelity | $23,332 | $16,12815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Manassas
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Celeste MullinsBig Stone Gap$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.